A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive Disorder
NCT00345098
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
704
Enrollment
INDUSTRY
Sponsor class
Conditions
Depressive Disorder
Major Depression
Interventions
DRUG:
SR58611A
Sponsor
Sanofi